Molecular interacting sites of 23s ribosomal rna and methods of modulating the same
CA 2458205 A1 · Owner: Isis Pharmaceuticals, Inc. · Inventors: Ecker, David J.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Polynucleotides comprising molecular interaction sites of 23S rRNA that have particular secondary structure are provided. Methods of using such polynucleotides to screen, virtually or actually combinatorial libraries of , compounds that bind thereto are also provided. Method of modulating the activity of 23S rRNA by contacting 23S rRNA or prokaryotic cells containing the same with a compund identified by such virtual or actual screening are also provided.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 21, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended August 21, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 21, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.